-
公开(公告)号:ZA741172B
公开(公告)日:1975-01-29
申请号:ZA741172
申请日:1974-02-22
Applicant: HOECHST AG
Inventor: KINSTMANN R , GRANZER E
IPC: A61K31/47 , C07D217/22 , C07D217/24 , C07D221/20 , C07D
-
52.
公开(公告)号:ZA733891B
公开(公告)日:1974-05-29
申请号:ZA733891
申请日:1973-06-08
Applicant: HOECHST AG
Abstract: Pharmaceutical compositions acting on the metabolism which contain as active substance bis(4-hydroxy-phenyl)alkanoic acids corresponding to the formulae I and II wherein R1 and R2 wich may be identical or different, each stands for a hydrogen or halogen atom or an alkyl group having 1 to 4 carbon atoms, R3 stands for a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R4 stands for hydroxy, alkoxy having 1 to 18 carbon atoms, phenyl-alkoxy having 1 to 4 alkyl carbon atoms, cycloalkoxy having 5 to 8 carbon atoms or a group of the formula in which Z and Z', which may be identical or different, each stands for hydrogen, alkyl of 1 to 18 carbon atoms, phenyl or cycloalkyl of 5 to 8 carbon atoms, or both together with the nitrogen atom may form a heterocyclic ring, R6 stands for an alkylene radical having 2 to 12 atoms and n stands for zero or an integer of 1 to 6, and process for preparing them.
-
53.
-
公开(公告)号:SE433493B
公开(公告)日:1984-05-28
申请号:SE7714684
申请日:1977-12-22
Applicant: HOECHST AG
Inventor: GEBERT U , GRANZER E , GREVE H-G , THORWART W
IPC: C07D295/08 , A61K31/445 , A61K31/451 , A61K31/495 , A61P3/06 , A61P9/00 , A61P9/10 , A61P9/12 , A61P19/06 , C07D209/14 , C07D211/14 , C07D213/53 , C07D213/80 , C07D295/088 , C07D303/12 , C07D303/36 , C07D333/22 , C07D409/12 , C07D295/12
Abstract: Compounds of general formula (I) wherein R1 represents a member selected from the group consisting of (a) an unsubstituted at most binuclear aryl group having from 6 to 10 carbon atoms, such groups substituted by from 1 to 3 equal or different radicals selected from the group consisting of alkyl, halogenoalkyl, alkoxy, dialkylamino each having up to 4 carbon atoms in the alkyl moiety, halogen phenyl, carboxyl, cyano, nitro and hydroxy groups, (b) a 5- to 6-membered heteroaromatic ring wherein the heteroatom is selected from nitrogen, oxygen and sulfur atoms and such rings anellated to a benzene nucleus; R2 represents a member selected from the group consisting of hydrogen, alkyl having up to 3 carbon atoms, phenyl, cycloalkyl having up to 6 carbon atoms in the ring and cycloalkyl bearing a hydrocarbon bridging radical having up to 2 carbon atoms; R3 represents hydrogen, hydroxy or acyloxy; R4 and R5 are the same or different and each represents a member selected from the group consisting of halogen, alkyl, and halogenoalkyl each having up to 3 carbon atoms, and nitro; and X represents nitrogen or methine and physiologically acceptable acid addition salts thereof and a pharmaceutical composition containing said compounds.
-
公开(公告)号:DK581181A
公开(公告)日:1982-07-01
申请号:DK581181
申请日:1981-12-29
Applicant: HOECHST AG
IPC: A61K31/425 , A61K31/426 , A61P3/06 , A61P9/10 , C07D277/18 , C07D277/20 , C07D277/42 , C07D
-
公开(公告)号:ZA803979B
公开(公告)日:1981-06-24
申请号:ZA803979
申请日:1980-07-02
Applicant: HOECHST AG
IPC: A61K31/425 , A61K31/426 , A61P3/06 , A61P9/10 , C07C275/66 , C07C335/36 , C07D277/18 , C07D277/20 , C07D277/42 , C07D317/66 , C07D319/18 , C07D417/12 , C07D
Abstract: Thiazoline derivatives of the general formula I (I) wherein R1 to R7 have the specified meanings, physiologically acceptable acid addition salts thereof, processes for their preparation, pharmaceutical preparations based on these compounds and their use for acting on the serum lipoprotein spectrum. The invention moreover relates to compounds of the formulae (IV) (XI) (XVII) wherein A, R, R1 to R7, Y and Z have the specified meanings.
-
公开(公告)号:AU6003780A
公开(公告)日:1981-01-15
申请号:AU6003780
申请日:1980-07-02
Applicant: HOECHST AG
IPC: A61K31/425 , A61K31/426 , A61P3/06 , A61P9/10 , C07C275/66 , C07C335/36 , C07D277/18 , C07D277/20 , C07D277/42 , C07D317/66 , C07D319/18 , C07D417/12 , C07D277/38
Abstract: Thiazoline derivatives of the general formula I (I) wherein R1 to R7 have the specified meanings, physiologically acceptable acid addition salts thereof, processes for their preparation, pharmaceutical preparations based on these compounds and their use for acting on the serum lipoprotein spectrum. The invention moreover relates to compounds of the formulae (IV) (XI) (XVII) wherein A, R, R1 to R7, Y and Z have the specified meanings.
-
公开(公告)号:SE412388B
公开(公告)日:1980-03-03
申请号:SE1699972
申请日:1972-12-27
Applicant: HOECHST AG
IPC: C07D233/54 , C07D233/64 , C07D235/12 , C07D235/18 , C07D235/20 , C07D403/06 , C07D235/06
Abstract: Pharmaceutical preparations having hypolipidemic activity, which contain in addition to a pharmaceutically acceptable carrier an effective amount of an imidazolyl-(2)-carbinol of the general formula I (I) in which R represents hydrogen, lower alkyl, phenyl or benzyl, R1 and R2 each represent hydrogen or together the group -CH=CH-CH=CH-, R3 and R4 represent hydrogen, lower alkyl, phenyl, lower haloalkyl, lower alkylphenyl, lower alkoxyphenyl, lower haloalkoxyphenyl, mono- or dihalophenyl, imidazolyl or benzylimidazolyl or R3 and R4 are together fluoryl of the formula or of a physiologically tolerable acid addition salt thereof, and process for preparing them.
-
公开(公告)号:NZ185105A
公开(公告)日:1979-12-11
申请号:NZ18510577
申请日:1977-09-06
Applicant: HOECHST AG
IPC: A61K31/425 , A61K31/428 , A61P3/06 , C07C45/63 , C07C205/45 , C07D277/60 , C07D277/84 , C07D513/04
Abstract: Thiazolidine derivatives of the formula I I in which the substituents R1 to R7 have the meanings as indicated in the following and which have in the free form or in the form of their non toxic acid addition salts valuable pharmaceutical properties, processes for preparing them, pharmaceutical preparations on the basis of these compounds and their use as medicines.
-
公开(公告)号:DK139428C
公开(公告)日:1979-07-30
申请号:DK271474
申请日:1974-05-17
Applicant: HOECHST AG
Inventor: KUNSTMANN R , GRANZER E
IPC: C07D221/16
Abstract: Partially hydrogenated 1H-indeno[1,2-b]-pyridine derivatives of the general formula I in which R1 and R2, which may be identical or different, represent hydrogen, halogen or alkoxy of 1 to 4 carbon atoms, R3 represents pyridyl, phenyl, or phenyl mono- or di-substituted by halogen, nitro, amino, acylamino, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, or amino substituted by 1 or 2 aliphatic or aromatic hydrocarbon groups having 2 to 18 carbon atoms or substituted amino wherein the amino-nitrogen is included in a heterocycle, A represents a single or double bond, and X represents oxygen or sulfur, AND THEIR PHYSIOLOGICALLY TOLERATED SALTS, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
-
-
-
-
-
-
-
-
-